Patent details

EP2397130 Title: Retinal derivatives for use in the treatment of visual disorders

Basic Information

Publication number:
EP2397130
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP111639399
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Retinal derivatives for use in the treatment of visual disorders
French Title of Invention:
Dérivés du rétinal pour le traitement de troubles visuels
German Title of Invention:
Retinalderivate zur Behandlung von Sehstörungen
SPC Number:

Dates

Filing date:
20/06/2005
Grant date:
03/04/2019
EP Publication Date:
21/12/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/04/2019
EP B1 Publication Date:
03/04/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/06/2019
Expiration date:
20/06/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/03/2019
 
 

Name:
University of Washington
Address:
Intellectual Property and Technology Transfer, 4311, 11th Avenue NE Suite 500, Campus Box 354990, Seattle, WA 98105-4608, United States (US)

Inventor

1

Name:
Batten, Matthew
Address:
United States (US)

2

Name:
Palczewski, Krzysztof
Address:
United States (US)

Priority

Priority Number:
580889 P
Priority Date:
18/06/2004
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/22; A61K 31/225; C07C 403/10; C07C 403/12; C07C 403/14; C07C 403/20;

Publication

European Patent Bulletin

Issue number:
201914
Publication date:
03/04/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages